CT

ConvaTec Group PLC (CTEC)

HealthcareMedical Instruments & Supplies
211.60GBX
-0.66%
Magic Rank
#181
Earnings Yield
7.6%
Return on Capital
128.2%
Market Cap
4.1B

Performance vs S&P 500 (5Y)

CTEC.LSE
S&P 500

About ConvaTec Group PLC

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Magic Formula Analysis

Enterprise Value5.5B
Market / Universe
gb
United Kingdom

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio35.13
Dividend Yield3.5%
Debt to Equity0.89
Gross Margin18.1%